Treating Cancer With Precision
News
Categories
Sign up
Featured Posts
Archive
Follow Us
- Nov 26, 2019
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
- Aug 22, 2018
Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St
The new Sealed Source and Device (SSD) approval enables the commencement of clinical trials in leading hospitals across the U.S. with the...
- Aug 22, 2018
Israeli Medical Startups Beat a Path to Aging Japan
[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation...
- Jul 15, 2018
CEO Uzi Sofer Reveals Great News on Galatz Radio 02.07.2018
Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for...